Literature DB >> 25629018

The association between oxidative stress and bone mineral density according to menopausal status of Korean women.

Young Joo Lee1, Ji Yun Hong1, Seung Chul Kim1, Jong Kil Joo1, Yong Jin Na1, Kyu Sup Lee1.   

Abstract

OBJECTIVE: The aim of this study is to investigate the association between oxidative stress and bone mineral density (BMD) according to menopausal status of Korean women.
METHODS: A total of 2,232 women who visited to the health promotion center at Pusan National University Hospital between 2010 and 2014 were included in this cross-sectional study. Laboratory tests, such as uric acid, albumin, total bilirubin, which were evaluated as a natural antioxidants. Homocysteine also was evaluated as a factor associated with oxidative stress. Correlation analyses and partial correlation coefficient between BMD scores and laboratory parameters associated with oxidative stress according to menopausal status were performed with Pearson test.
RESULTS: By correlation analysis, uric acid had only positive correlation with femur and lumbar BMD in premenopausal and postmenopausal group. But albumin and bilirubin, which were the other natural antioxidants, had no correlation with BMD except total bilirubin with femur BMD in postmenopausal group. Homocysteine had negative correlation with femur BMD in postmenopausal group. But there were different results in partial correlation coefficient adjusted by age and BMI. In premenopausal group, uric acid was still positive correlation with femur and lumbar BMD, whereas in postmenopausal group homocysteine had no correlation with femur BMD, total bilirubin and uric acid had no correlation with lumbar BMD. At the multiple logistic regressions, only age and menopause status, uric acid had correlation with BMD.
CONCLUSION: In this study, homocysteine had no correlation with BMD. But in natural antioxidant, uric acid had only positive correlation with BMD.

Entities:  

Keywords:  Bone density; Homocysteine; Menopause; Uric acid

Year:  2015        PMID: 25629018      PMCID: PMC4303752          DOI: 10.5468/ogs.2015.58.1.46

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


Introduction

Osteoporosis is an important health problem and a major predisposing factor for fracture. As the population aging, the prevalence of osteoporosis gets higher and the social burden increasing. So it has been an important subject to investigate the factors that influence the occurrence of osteoporosis. Some of them were modifiable factors such as smoking, alcohol consumption, low calcium intake and others were not modifiable factors such as aging, female gender, menopause [1,2,3]. Recently, oxidative stress or low circulating levels of antioxidants were proposed to be related with reduced bone mineral density (BMD) and caused osteoporosis by in vitro studies or animal studies [4,5,6]. Uric acid, bilirubin and albumin has been known as natural antioxidants. Actually, it has been reported that higher uric acid levels were linearly associated with higher lumbar spine BMD in perimenopausal and postmenopausal women. It might be due to the major role of uric acid in free radical scavenger activity [7]. Bilirubin suppressed oxidation and albumin was an important contributor to maintain total antioxidant status [8,9]. So, the antioxidant activity by these factors could be influence the BMD. On the contrary, homocysteine was a factor associated with oxidative stress in vivo [8,10]. But, the relationship between homocysteine and BMD is still unclear. Some studies reported that high homocysteine was related with increased bone turnover and fracture risk in elderly [11,12], but other studies didn't [13,14]. Homocysteine level might be changed with endogenous sex steroids levels [15]. So, the change of homocysteine levels through the menopausal transition may have influence on the decrease of BMD or development of osteoporosis in postmenopausal women. The research for the relationship of natural antioxidants and BMD could confirm the influence of oxidative stress for development of osteoporosis and the natural antioxidants levels could be used as variables predicting the occurrence of osteoporosis. The aim of this study is to investigate the association between oxidative stress and BMD according to menopausal status of Korean women.

Materials and methods

1. Study population and anthropometric measurements

A total of 2,232 women who visited to the health promotion center at Pusan National University Hospital between 2010 and 2014 were included in this cross-sectional study. Demographic data were collected at the time of the visit. Information on menstrual history, lifestyle, disease history and medication history were obtained with self-report questionnaires and interviews with healthcare providers. Body weight and height were measured when standing barefoot, up to 0.1 kg and 0.1 cm, respectively. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. We conducted our research based on self-report questionnaires. We included patients prepared our self-report questionnaires without exception and excluded patients who had been taking a steroid medicine for asthma, arthritis, rheumatic disease, which could affect BMD and also excluded patients taking a bisphosphonate and selective estrogen-receptor modulator. But we included 390 hypertension patients, 95 diabetes patients, 353 hyperlipidemia patient, all these patients had been taking a medication, 115 smokers. We also included patients had been taking a vitamin D or calcium medication on our research.

2. Blood sampling and laboratory analysis

Bloods were obtained from antecubital vein from all subjects between 8:30 and 10:00 a.m., after fasting for at least eight hours. Laboratory tests were evaluated, which consisted of uric acid, albumin, total bilirubin as a natural antioxidants and homocysteine as a factor associated with oxidative stress. BMD was measured by dual-energy X-ray absorptiometry (Hologic QDR-4500A, Bedford, MA, USA) at the lumbar spine (L1-L4), femur neck and femur total. BMD results were classified into three groups according to World Health Organization criteria (normal BMD, T-score ≥-1; osteropenia, -2.5< T-score <-1; and osteroporosis, T-score ≤-2.5, respectively) [16]. Intraassay and interassay coefficients of variation of uric acid were 1.0% and 1.3%, albumin were 1.6% and 0.9%, total bilirubin were 2.7% and 2.6%, homocysteine were 4.4% and 3.3%, BMD were 2.3% and 2.7%.

3. Statistical analysis

PASW ver. 18.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. All data were entered into a database and were verified by a second independent person. Data were presented as mean±standard deviation for normally distributed variables (age, BMI, albumin, total bilirubin, homocysteine, and uric acid). The study population was divided into two groups, premenopause and postmenopause. Menopause group was categorized according to self questionnaires. If the patient had a hysterectomy, menopause was diagnosed by serum follicle stimulating hormone level. Serum follicle stimulating hormone more than 40 IU/mL was used for diagnosis of menopause. The differences in baseline characteristics between groups were analyzed by Student's t-test. Correlation analyses and partial correlation coefficients were performed with Pearson test. Logistic regression analysis was performed to identify significant independent related factors for osteoporosis. Two-sided values of P<0.05 were considered as statistically significant.

Results

The demographics and laboratory parameters of the study participants were presented in Table 1. There were statistically significant differences on age, BMI, uric acid level between two groups (P<0.05).
Table 1

Demographics and laboratory parameters of study population

Data are presented as the mean±standard deviation.

a)Student's t-test.

The correlation analysis results between oxidative stress markers with BMD scores according to menopausal status were summarized in Tables 2 and 3. Uric acid was a sole parameter that had significantly positive correlation with femur and lumbar BMD in premenopausal group with strongly, but the magnitude of correlation was small (r=0.143, P=0.000). In postmenopausal group, uric acid was positively correlated with lumbar BMD (r=0.095, P=0.000). Homocysteine had negative correlation significantly with femur BMD (r=-0.074, P=0.038). A positive correlation was found between total bilirubin level and femur BMD scores (r=0.069, P=0.010). But there were different results in partial correlation coefficient adjusted by age and BMI. In premenopausal group, uric acid was still positive correlation with femur and lumbar BMD, whereas in postmenopausal group homocysteine had no correlation with femur BMD (r=-0.032, P=0.372), total bilirubin and uric acid had no correlation with lumbar BMD.
Table 2

Correlation coefficients between bone mineral density scores and laboratory parameters associated with oxidative stress in premenopausal women

a)Pearson's correlation coefficient; b)Partial correlation coefficient adjusted by age and body mass index.

Table 3

Correlation coefficients between bone mineral density scores and laboratory parameters associated with oxidative stress in postmenopausal women

a)Pearson's correlation coefficient; b)Partial correlation coefficient adjusted by age and body mass index.

Table 4 showed the results of multiple logistic regression analyses. BMD was calculated as continuous variable parameters and we investigated correlation of serial BMD score and several factors (uric acid, homocysteine, albumin, and total bilirubin). Cumulative logistic regression analyses revealed that age (odds ration [OR], 0.934; 95% confidence interval [CI], 0.914 to 0.954; P<0.000), menopause (OR, 0.323; 95% CI, 0.214 to 0.491; P<0.000) and uric acid (OR, 1.208; 95% CI, 1.100 to 1.302; P<0.000) were independent variables associated with increasing lumbar and femur BMD.
Table 4

Cumulative logistic regression analysis results of the possible correlates for lumbar (L1-L4) and femur bone mineral density

Discussion

Oxidative stress has been proposed as an underlying mechanism of many diseases such as cancer, atherosclerosis, rheumatoid arthritis and osteoporosis [17]. Oxidative stress may cause osteoporosis by altering the function of osteoclast and osteoblast. Architecture of bone is maintained by continuous destruction and renewal of bone. These continuous remodeling of bone are regulated by balanced action of osteoclast and osteoblast. In osteoporosis patients, the ratio of superoxide dismutase and glutathione peroxidase, which were oxidative stress biological markers, were increased and it favors the increase in H2O2 levels [18,19]. High H2O2 levels developed the differentiation of osteoblastic cells to osteoclasts and inhibit the differentiation of osteoblastic cells to osteoblasts [20,21]. In addition, there were some reports that explained the effect of antioxidants to the development of osteoporosis. Low serum albumin reflected significant systemic inflammation and bone resorption had been found to be increased by systemic inflammation as a result of increased number of various cytokines [22]. There have been several epidemiological analyses that had shown a significant inverse association between total bilirubin and BMD in patients with or without underlying liver disease [23,24,25]. Low intake of antioxidant vitamins increased the risk of hip fracture in smoker [26]. Maggio et al. [27] also showed possible link between plasma antioxidants and BMD in osteoporotic women. Despite of this clear causal relationship between oxidative stress and osteoporosis, factors that affect natural antioxidant have not been well identified. One of suggested factors is homocysteine. Homocysteine caused the production of reactive oxygen species by autooxidation [28]. Theoretically, homocysteine has negative effect on antioxidant and bone. But conflicting results have been reported about the relationship of homocysteine and bone. Bucciarelli et al. [29] reported that total plasma homocysteine was negatively associated with the variance of BMD of the total femur. The association was clinically relevant but the contribution of homocysteine to BMD was small (2% of the total variance). On the contrary, Dhonukshe-Rutten et al. [30] and Fleming et al. [31] showed no relation between homocysteine and BMD. The transition of homocysteine level after menopause is also unclear. It has been reported that homocysteine was lower in premenopausal as compared to postmenopausal women [32]. However other researchers reported that menopause did not affect the homocysteine levels [33,34,35]. In this study, the average level of homocysteine was higher in the postmenopausal women but there was no statistical difference between premenopausal and postmenopausal women. On BMD, homocysteine had weakly negative correlation only in femur and no relationship with osteopenia or osteoporosis (data was not shown) and no correlation with BMD on cumulative logistic regression analysis. Albumin and total bilirubin were also showed weak or no relationship with BMD. Therefore, homocysteine, albumin and total bilirubin seemed not to be good parameters to predict the BMD in Korean women. Also, by the study of Kim et al. [36], serum homocysteine levels were not correlated with BMD in middle aged Korean women and it showed similar results of this study. Considering these results, homocysteine may have little significance on the correlation or prediction of BMD in Korean women. Actually homocysteine is influenced by many factors like age, race, alcohol intake, smoking, renal function and nutritional state [37,38,39]. Therefore, it may need homocysteine measurements under serial and more subdivided situation to confirm the relationship of homocysteine and BMD. In point of the correlation of BMD and oxdative-antioxidative factors, Uric acid showed correlation with femur and lumbar BMD in premenopause and only lumbar BMD in postmenopause. Because the normal discordance of lumbar and femur BMD after menopause by increasing body fat mass was one of the reason for changes of statistical relationship of uric acid and BMD between premenopause and postmenopause women [40]. But uric acid and femur BMD in postmenopause showed tendency to positive correlation in our study (P=0.051). But there were different results in partial correlation coefficient adjusted by age and BMI. In premenopausal group, uric acid was still positive correlation with femur and lumbar BMD but it had no correlation with lumbar BMD in postmenopausal group. At cumulative logistic regression analyses, age, menopause state and uric acid were the independent factors that affect the lumbar and femur BMD. Ishii et al. [41] reported similar result. From these results, we can assume that uric acid is the leading natural anti-oxidant affecting BMD and might be used as a marker to represent natural antioxidative state. This study was conducted to the women who visited health promotion center to check-up voluntary. The composition of object group in this study might give influence to the result. Also, there were plenty of oxidative and antioxidative parameters in vivo and the relation of these factors were much more complicated. Nevertheless these limitations, this study has values to show the relationship of natural antioxidant and BMD, and the changes of natural antioxidant depending on the menopausal status. This study examined limited kinds of natural antioxidant. Research for other natural antioxidants will be clearly revealed the association of BMD and oxidative stress and further investigation will be needed.
  40 in total

1.  Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study.

Authors:  Dario Maggio; Mauro Barabani; Marco Pierandrei; M Cristina Polidori; Marco Catani; Patrizia Mecocci; Umberto Senin; Roberto Pacifici; Antonio Cherubini
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

2.  Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease.

Authors:  Lu-Qin Bian; Rong-Zhen Li; Zheng-Yun Zhang; Yan-Ji Jin; Hyung-Wook Kang; Zhen-Zhu Fang; Youn-Soo Park; Yoon-Ho Choi
Journal:  J Bone Miner Metab       Date:  2013-04-12       Impact factor: 2.626

3.  Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans.

Authors:  Martha Savaria Morris; Paul F Jacques; Jacob Selhub
Journal:  Bone       Date:  2005-08       Impact factor: 4.398

4.  Determinants of the rate of bone loss in normal postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; S J Sharpe; G D Gamble
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

5.  Oxidative stress modulates osteoblastic differentiation of vascular and bone cells.

Authors:  N Mody; F Parhami; T A Sarafian; L L Demer
Journal:  Free Radic Biol Med       Date:  2001-08-15       Impact factor: 7.376

6.  Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation.

Authors:  Jenny M Lean; Chris J Jagger; Barrie Kirstein; Karen Fuller; Timothy J Chambers
Journal:  Endocrinology       Date:  2004-11-04       Impact factor: 4.736

7.  Homocysteine levels and risk of hip fracture in postmenopausal women.

Authors:  Meryl S Leboff; Rupali Narweker; Andrea LaCroix; Lieling Wu; Rebecca Jackson; Jennifer Lee; Douglas C Bauer; Jane Cauley; Charles Kooperberg; Cora Lewis; Asha M Thomas; Steven Cummings
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

8.  Homocysteine levels and the risk of osteoporotic fracture.

Authors:  Joyce B J van Meurs; Rosalie A M Dhonukshe-Rutten; Saskia M F Pluijm; Marjolein van der Klift; Robert de Jonge; Jan Lindemans; Lisette C P G M de Groot; Albert Hofman; Jacqueline C M Witteman; Johannes P T M van Leeuwen; Monique M B Breteler; Paul Lips; Huibert A P Pols; André G Uitterlinden
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

9.  Copper, zinc-superoxide dismutase and hydrogen peroxide: a hydroxyl radical generating system.

Authors:  J C Koningsberger; B S van Asbeck; E van Faassen; L J Wiegman; J van Hattum; G P van Berge Henegouwen; J J Marx
Journal:  Clin Chim Acta       Date:  1994-10-14       Impact factor: 3.786

10.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more
  14 in total

1.  Association between serum uric acid and bone health in adolescents.

Authors:  F Karimi; M H Dabbaghmanesh; G R Omrani
Journal:  Osteoporos Int       Date:  2019-07-04       Impact factor: 4.507

2.  Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.

Authors:  M Pirro; M R Mannarino; V Bianconi; S De Vuono; A Sahebkar; F Bagaglia; L Franceschini; A M Scarponi; E Mannarino; T Merriman
Journal:  Osteoporos Int       Date:  2016-10-10       Impact factor: 4.507

3.  Serum biomarker-based osteoporosis risk prediction and the systemic effects of Trifolium pratense ethanolic extract in a postmenopausal model.

Authors:  Yixian Quah; Jireh Chan Yi-Le; Na-Hye Park; Yuan Yee Lee; Eon-Bee Lee; Seung-Hee Jang; Min-Jeong Kim; Man Hee Rhee; Seung-Jin Lee; Seung-Chun Park
Journal:  Chin Med       Date:  2022-06-14       Impact factor: 4.546

4.  The Association between Serum Uric Acid and Bone Mineral Density in Older Adults.

Authors:  Xiaocong Yao; Lin Chen; Huihui Xu; Zhongxin Zhu
Journal:  Int J Endocrinol       Date:  2020-06-29       Impact factor: 3.257

5.  Status of trace elements and antioxidants in premenopausal and postmenopausal phase of life: a comparative study.

Authors:  Sabah Ansar; Tayef Alhefdhi; Ansari M Aleem
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss.

Authors:  X L Dong; W X Yu; C M Li; S He; L P Zhou; C W Poon; M S Wong
Journal:  Osteoporos Int       Date:  2017-10-23       Impact factor: 4.507

7.  No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity--a Mendelian randomization study.

Authors:  A Xiong; Q Yao; J He; W Fu; J Yu; Z Zhang
Journal:  Osteoporos Int       Date:  2015-11-20       Impact factor: 4.507

8.  Bone mineral density and oxidative stress in adolescent girls with anorexia nervosa.

Authors:  Alžbeta Čagalová; Ľubica Tichá; Alexandra Gaál Kovalčíková; Katarína Šebeková; Ľudmila Podracká
Journal:  Eur J Pediatr       Date:  2021-07-22       Impact factor: 3.183

9.  No association between serum uric acid and lumbar spine bone mineral density in US adult males: a cross sectional study.

Authors:  Xiaoli Li; Lianju Li; Lixian Yang; Jiaxun Yang; Hua Lu
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

10.  Evaluation of Glutathione-S-Transferase P1 Polymorphism and its Relation to Bone Mineral Density in Egyptian Children and Adolescents with Beta-Thalassemia Major.

Authors:  Seham M Ragab; Eman A Badr; Ahmed S Ibrahim
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.